EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing Precision Medicine in Paediatrics: Past, present and future

Abdelbaset Elzagallaai, Charlotte Barker, Tamorah Lewis, Ronald Cohn, Michael Rieder iD

Cambridge Prisms: Precision Medicine · 2023

DOI: 10.1017/pcm.2022.14 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, 2023. Verfasst von Abdelbaset Elzagallaai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute of Human Development, Child and Youth Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision Medicine is an approach to disease treatment and prevention taking into account individual genetic, environmental, therapeutic and lifestyle variability for each person. This holistic approach to therapeutics is intended to enhance drug efficacy and safety not only across healthcare systems but for individual patients. While weight and to some extent gestational age have been considered in determining drug dosing in children, historically other factors including genetic variability have not been factored into therapeutic decision making. As our knowledge of the role of ontogeny and genetics in determining drug efficacy and safety has expanded, these insights have provided new opportunities to apply principles of Precision Medicine to the care of infants, children and youth. These opportunities are most likely to be achieved first in select sub-groups of children. While there are many challenges to the successful implementation of Precision Medicine in children including the need to ensure that Precision Medicine enhances rather than reduces equity in children’s health care rather, there are many more opportunities. Research, advocacy, planning and teamwork are required to move Precision Medicine forward in children in pursuit of the common goal of safe and effective drug therapy.

Schlagwörter

Stichwörter der Autor:innen

drug safetypaediatricspharmacogenomicsprecision medicinetherapeutics

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, University of Western Ontario, London, ON, Canada.
  • Department of Medical and Molecular Genetics, King's College London, London, UK.
  • Department of Paediatrics, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Departments of Paediatrics, Physiology & Pharmacology and Medicine, University of Western Ontario, London, ON, Canada.

ORCID-Profile: Michael Rieder

Förderung

  • Institute of Human Development, Child and Youth Health

Zitieren

APA

Elzagallaai, A., Barker, C., Lewis, T., Cohn, R., & Rieder, M. (2023). Advancing Precision Medicine in Paediatrics: Past, present and future. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2022.14

Vancouver

Elzagallaai A, Barker C, Lewis T, Cohn R, Rieder M. Advancing Precision Medicine in Paediatrics: Past, present and future. Cambridge Prisms: Precision Medicine. 2023. doi:10.1017/pcm.2022.14

BibTeX
@article{Elzagallaai2023,
  author = {Elzagallaai, Abdelbaset and Barker, Charlotte and Lewis, Tamorah and Cohn, Ronald and Rieder, Michael},
  title = {Advancing Precision Medicine in Paediatrics: Past, present and future},
  journal = {Cambridge Prisms: Precision Medicine},
  year = {2023},
  doi = {10.1017/pcm.2022.14}
}
Kostenlos starten →